311 related articles for article (PubMed ID: 8889834)
1. Reversible affinity labeling of opioid receptors via disulfide bonding: discriminative labeling of mu and delta subtypes by chemically activated thiol-containing enkephalin analogs.
Yasunaga T; Motoyama S; Nose T; Kodama H; Kondo M; Shimohigashi Y
J Biochem; 1996 Aug; 120(2):459-65. PubMed ID: 8889834
[TBL] [Abstract][Full Text] [Related]
2. Exploration of universal cysteines in the binding sites of three opioid receptor subtypes by disulfide-bonding affinity labeling with chemically activated thiol-containing dynorphin A analogs.
Shirasu N; Kuromizu T; Nakao H; Chuman Y; Nose T; Costa T; Shimohigashi Y
J Biochem; 1999 Jul; 126(1):254-9. PubMed ID: 10393346
[TBL] [Abstract][Full Text] [Related]
3. Affinity labeling of delta-opiate receptors using [D-Ala2,Leu5,Cys6]enkephalin. Covalent attachment via thiol-disulfide exchange.
Bowen WD; Hellewell SB; Kelemen M; Huey R; Stewart D
J Biol Chem; 1987 Oct; 262(28):13434-9. PubMed ID: 2820969
[TBL] [Abstract][Full Text] [Related]
4. Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain.
Ni Q; Xu H; Partilla JS; Rice KC; Matecka D; Calderon SN; Porreca F; Lai J; Schmidhammer H; Krassnig R; Rothman RB
Peptides; 1998; 19(6):1079-90. PubMed ID: 9700759
[TBL] [Abstract][Full Text] [Related]
5. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
Cruciani RA; Lutz RA; Munson PJ; Rodbard D
J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and receptor binding characteristics of [D-Ala2, cysteamine 5] enkephalin, a thiol-containing probe for structural elements of opiate receptors.
Kodama H; Shimohigashi Y; Costa T; Kondo M
Int J Pept Protein Res; 1988 Jul; 32(1):41-6. PubMed ID: 2851562
[TBL] [Abstract][Full Text] [Related]
8. Discriminative affinity labelling of opioid receptors by enkephalin and morphiceptin analogues containing 3-nitro-2-pyridinesulphenyl-activated thiol residues.
Shimohigashi Y; Takada K; Sakamoto H; Matsumoto H; Yasunaga T; Kondo M; Ohno M
J Chromatogr; 1992 Apr; 597(1-2):425-8. PubMed ID: 1325466
[TBL] [Abstract][Full Text] [Related]
9. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
Szatmári I; Orosz G; Medzihradszky K; Borsodi A
Biochem Biophys Res Commun; 1999 Nov; 265(2):513-9. PubMed ID: 10558900
[TBL] [Abstract][Full Text] [Related]
10. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).
Spain JW; Roth BL; Coscia CJ
J Neurosci; 1985 Mar; 5(3):584-8. PubMed ID: 2983043
[TBL] [Abstract][Full Text] [Related]
11. Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide.
Shahrestanifar M; Wang WW; Howells RD
J Biol Chem; 1996 Mar; 271(10):5505-12. PubMed ID: 8621408
[TBL] [Abstract][Full Text] [Related]
12. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
[TBL] [Abstract][Full Text] [Related]
13. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
Wang WW; Shahrestanifar M; Jin J; Howells RD
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
[TBL] [Abstract][Full Text] [Related]
14. [Heterogeneity of mu- and delta-opioid active sites in the mouse cerebral cortex. Selective increase in the affinity of a superhigh affinity delta-site during long-term administration of morphine].
Zaĭtsev SV; Il'ina AD; Klodt PM; Varfolomeev SD; Iukhananov RIu
Biokhimiia; 1992 Aug; 57(8):1242-7. PubMed ID: 1327189
[TBL] [Abstract][Full Text] [Related]
15. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
Clark JA; Houghten R; Pasternak GW
Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
[TBL] [Abstract][Full Text] [Related]
16. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
Bowen WD; Kelemen M; Huey R; Stewart D
NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
[TBL] [Abstract][Full Text] [Related]
17. Opioid ligand binding sites in the spinal cord of the guinea-pig.
Zarr GD; Werling LL; Brown SR; Cox BM
Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
[TBL] [Abstract][Full Text] [Related]
18. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites.
Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
J Neurochem; 1985 Sep; 45(3):677-87. PubMed ID: 2993509
[TBL] [Abstract][Full Text] [Related]
19. Discriminative disulfide-bonding affinity labeling of opioid receptor subtypes.
Shirasu N; Shimohigashi Y
J Biochem Biophys Methods; 2001 Oct; 49(1-3):587-606. PubMed ID: 11694304
[TBL] [Abstract][Full Text] [Related]
20. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
